Page last updated: 2024-08-23

miglustat and Osteolysis

miglustat has been researched along with Osteolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alonzi, DS; Antonopoulos, A; Butters, TD; Chaidos, A; Danks, L; Dell, A; Dwek, RA; Ersek, A; Freidin, A; Goudevenou, K; Haslam, SM; Hatjiharissi, E; Horwood, NJ; Hu, M; Karadimitris, A; Papaioannou, M; Parry, S; Rahemtulla, A; Roberts, I; Santo, AE; Spanoudakis, E; Twigg, G; Vattakuzhi, Y; Williams, LM; Xu, K	1

Other Studies

1 other study(ies) available for miglustat and Osteolysis

Article	Year
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. The Journal of clinical investigation, 2015, Volume: 125, Issue:6 Topics: 1-Deoxynojirimycin; Animals; Cell Line; CSK Tyrosine-Protein Kinase; Female; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Glycosphingolipids; Insulin-Like Growth Factor I; Membrane Microdomains; Mice; Mice, Knockout; Multiple Myeloma; Osteoclasts; Osteolysis; RANK Ligand; src-Family Kinases; TNF Receptor-Associated Factor 6	2015

Article

Year

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

The Journal of clinical investigation, 2015, Volume: 125, Issue:6

Topics: 1-Deoxynojirimycin; Animals; Cell Line; CSK Tyrosine-Protein Kinase; Female; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Glycosphingolipids; Insulin-Like Growth Factor I; Membrane Microdomains; Mice; Mice, Knockout; Multiple Myeloma; Osteoclasts; Osteolysis; RANK Ligand; src-Family Kinases; TNF Receptor-Associated Factor 6

2015